Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Introduction

Blood stem cell transplantation offers a curative option for patients with severe sickle cell disease. While the majority of patients with an HLA-identical sibling can be cured, the vast majority of patients do not have a suitable donor. On the other hand, most patients have a haploidentical (half-matched) parent, child, or sibling who can serve as the donor. This protocol uses a nonmyeloablative haploidentical approach for patients with severe sickle cell disease. The goal of the study is to reverse sickle cell disease with a decreased risk of toxicity.

To get started:

  • Navigate through the menu to learn more about the study.
  • Log in to the application and fill out questionnaires.

Please contact us if you have any questions or concerns.